Proteins from actinobacillus pleuropneumoniae
US6713071B1 · kind B1 · utility
7Cited by
12References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 14, 1999 |
| Grant date | Mar 30, 2004 |
| Priority date | — |
| Expiry date | Oct 14, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to five novel, low molecular weight proteins from Actinobacillus pleuropneumoniae (APP), which are capable of inducing, or contributing to the induction of, a protective immune response in swine against APP. The present invention is further directed to polynucleotide molecules having nucleotide sequences that encode the proteins, as well as vaccines comprising the proteins or polynucleotide molecules, and methods of making and using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.